| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥703.6B | ¥613.7B | +14.6% |
| Operating Income | ¥58.4B | ¥36.4B | +60.6% |
| Ordinary Income | ¥58.6B | ¥30.6B | +91.3% |
| Net Income | ¥34.9B | ¥21.1B | +65.2% |
| ROE | 4.2% | 2.7% | - |
FY2025 Q3 cumulative results: Revenue 703.6B yen (YoY +14.6%), Operating Income 58.4B yen (YoY +60.6%), Ordinary Income 58.6B yen (YoY +91.3%), Net Income 34.9B yen (YoY +65.2%). The company achieved significant profit expansion driven by revenue growth and operating margin improvement, with operating margin reaching 8.3% compared to 5.9% in the prior year period. Ordinary income growth of 91.3% exceeded operating income growth due to foreign exchange gains and financial income contributions. The equity ratio stands at 56.8% with total assets of 1,465.1B yen and equity of 831.5B yen, maintaining a conservative capital structure.
Revenue increased 89.9B yen YoY to 703.6B yen, representing 14.6% growth. The Agrochemicals segment recorded sales of 656.6B yen with operating income of 54.7B yen, while Chemicals Other Than Agrochemicals posted sales of 31.2B yen with operating income of 6.3B yen. The Other segment including landscaping, real estate leasing, logistics services, and agrochemical residue analysis contributed additional revenue. Operating income surged 22.0B yen YoY to 58.4B yen, driven primarily by improved gross profit margin of 34.7% and operating leverage effects. Gross profit reached 244.3B yen, with selling, general and administrative expenses of 185.9B yen, resulting in the 8.3% operating margin. Ordinary income of 58.6B yen reflected a 28.0B yen improvement YoY, with the gap between operating and ordinary income remaining minimal at 0.2B yen. Financial income included interest income of 15.3B yen and dividend income of 1.4B yen, while interest expense amounted to 20.2B yen. Foreign exchange gains of 11.1B yen contributed positively to non-operating income. Net income of 34.9B yen improved 13.8B yen YoY, with the conversion rate from ordinary to net income at 59.5%, indicating a tax burden coefficient of 0.814. This represents a revenue-up-profit-up pattern with accelerated profit growth exceeding revenue growth.
The Agrochemicals segment constitutes the core business, accounting for 95.4% of total reportable segment sales at 656.6B yen (YoY +14.9%) with operating income of 54.7B yen (YoY +53.3%). This segment demonstrates an operating margin of approximately 8.3%, reflecting improved profitability through volume growth and pricing effects. The Chemicals Other Than Agrochemicals segment generated sales of 31.2B yen (YoY +7.8%) with operating income of 6.3B yen (YoY +22.8%), achieving a higher operating margin of approximately 20.2%. This smaller segment exhibits superior profitability on a percentage basis despite its limited scale. The Other segment, encompassing landscaping, real estate leasing, logistics services, and agrochemical residue analysis, contributed sales of 15.8B yen with segment profit of 3.8B yen. Corporate costs not allocated to segments totaled 6.4B yen, down from 6.9B yen in the prior period, reflecting improved overhead management.
[Profitability] ROE 4.8% remains below the industry median of 5.2% but reflects improvement from operating margin expansion to 8.3% from 5.9% YoY, while net profit margin reached 5.7% compared to 3.4% YoY. ROIC of 6.0% and ROA of 2.7% indicate moderate capital efficiency with room for improvement. Interest coverage ratio of 2.90x shows limited buffer against interest rate increases, as interest expense of 20.2B yen against EBIT creates potential vulnerability. [Cash Quality] Cash and deposits totaled 262.1B yen (down 67.2B yen YoY) with short-term debt of 76.1B yen, providing cash coverage of 3.45x for near-term obligations. Inventory increased 89.5B yen to 317.8B yen (YoY +39.2%), raising concerns about working capital efficiency. Accounts receivable decreased significantly by 199.0B yen to 276.1B yen (YoY -41.9%), suggesting enhanced collection or period-end timing effects. [Investment Efficiency] Asset turnover of 0.480 remains below the industry median of 0.58, indicating suboptimal asset utilization. Operating working capital cycle appears extended based on balance sheet movements, with inventory days likely elevated. [Financial Health] Equity ratio of 56.8% compares favorably to the industry median of 63.8%, indicating conservative leverage. Current ratio of 251.5% and quick ratio of 178.8% demonstrate strong liquidity. Financial leverage of 1.76x aligns with industry median of 1.53x. Interest-bearing debt totaled 213.7B yen with debt-to-equity ratio of 0.76x and net debt-to-EBITDA estimated within manageable range, though interest coverage of 2.90x warrants monitoring.
Cash and deposits decreased 67.2B yen YoY to 262.1B yen, reflecting strategic deployment of liquidity despite operating profit growth. The significant accounts receivable reduction of 199.0B yen suggests accelerated collection or favorable period-end settlement timing, contributing positively to cash generation from operations. Conversely, inventory accumulation of 89.5B yen indicates working capital absorption, potentially reflecting production build-up ahead of anticipated demand or supply chain adjustments. Short-term borrowings declined 51.3B yen to 76.1B yen, demonstrating debt reduction and improved short-term liability structure. Intangible assets increased 16.8B yen to 36.6B yen (YoY +84.4%), likely reflecting investment in intellectual property, software systems, or acquisition-related intangibles, requiring monitoring for future amortization burden and impairment risk. The combination of reduced receivables and increased inventory suggests a shift in working capital composition, with overall cash coverage of short-term liabilities maintaining comfortable levels at 3.45x. The equity increase of 37.3B yen to 831.5B yen reflects retained earnings accumulation net of dividends, supporting balance sheet strengthening.
Ordinary income of 58.6B yen versus operating income of 58.4B yen indicates minimal non-operating impact of approximately 0.2B yen net contribution. Non-operating income composition includes interest and dividend income totaling 16.7B yen, foreign exchange gains of 11.1B yen, and other financial income as primary components. Interest expense of 20.2B yen represents the main non-operating cost. Non-operating items represent approximately 2.4% of revenue on a gross basis, with interest income of 15.3B yen and forex gains providing meaningful support to profitability. The near-parity between operating and ordinary income suggests core business performance drives overall results. The 13.6B yen gap between ordinary income of 58.6B yen and net income of 34.9B yen reflects a tax burden coefficient of 0.814 and interest burden coefficient of 0.838, indicating normalized tax and financing costs. The absence of operating cash flow disclosure limits assessment of earnings-to-cash conversion quality, creating uncertainty regarding whether reported profits translate to actual cash generation, particularly given the significant working capital movements in inventory and receivables.
Full-year guidance projects revenue of 1,093.0B yen (YoY +9.3%), operating income of 92.0B yen (YoY +7.3%), ordinary income of 80.0B yen (YoY +12.9%), and net income of 54.0B yen with EPS of 68.97 yen. Q3 cumulative progress rates stand at revenue 64.4%, operating income 63.5%, ordinary income 73.3%, and net income 64.6% against full-year targets. Given Q3 represents 75% of the fiscal year, revenue and operating income progress appear slightly behind the standard pace, while ordinary income shows ahead-of-schedule progress due to stronger-than-anticipated non-operating gains. The variance suggests Q4 must deliver approximately 389.4B yen in revenue and 33.6B yen in operating income to achieve targets, representing acceleration from current run rates. Net income progress of 64.6% implies remaining net income of 19.1B yen required in Q4, which appears achievable given current profitability trends. The forecast assumptions likely incorporate continued agrochemical demand, stable foreign exchange contributions, and controlled operating expenses, though specific guidance notes are not disclosed.
Annual dividend guidance stands at 15 yen per share, comprising interim dividend of 10 yen and planned year-end dividend of 12 yen (though cumulative interim already suggests 10 yen paid). Based on net income of 34.9B yen for Q3 cumulative and an implied share count, the payout ratio calculates to approximately 45.2% against current earnings, representing a sustainable level. Comparison to prior period dividends is not disclosed, limiting YoY dividend growth assessment. No share buyback programs are reported in the available data. The total return ratio equals the payout ratio of 45.2% in the absence of buyback activity, indicating moderate shareholder returns relative to earnings. Dividend coverage appears adequate given current profitability, though the lack of operating cash flow visibility creates uncertainty regarding cash-based dividend sustainability. The 15 yen annual dividend against forecasted EPS of 68.97 yen implies a 21.7% payout ratio on full-year guidance basis, suggesting conservative distribution policy with substantial earnings retention for business reinvestment.
Inventory accumulation risk poses the most immediate concern, with stock increasing 39.2% YoY to 317.8B yen against revenue growth of 14.6%, indicating inventory turnover deterioration and potential obsolescence or write-down risk if demand softens or product lifecycles shorten. Foreign exchange volatility represents material earnings variability, evidenced by 11.1B yen forex gains in the current period compared to prior period losses, creating uncertainty in ordinary income sustainability as exchange rate movements remain unpredictable and can reverse profitability contributions. Interest rate exposure presents increasing pressure with interest coverage ratio of 2.90x leaving limited cushion, as rising rates on the 213.7B yen interest-bearing debt base would compress margins and reduce net income, particularly given the current interest expense of 20.2B yen already representing significant burden relative to operating income.
[Industry Position] (Reference - Proprietary Analysis) The company's operating margin of 8.3% aligns closely with the manufacturing industry median of 8.7%, positioning within the interquartile range of 5.1% to 12.6%, indicating competitive but not exceptional operating efficiency. Net profit margin of 5.7% falls within the industry IQR of 3.3% to 9.3% and slightly below the 6.4% median, suggesting typical profit conversion for the sector. ROE of 4.8% tracks below the industry median of 5.2%, placing the company in the lower half of manufacturing peers and indicating room for capital efficiency improvement. Asset turnover of 0.480 significantly underperforms the industry median of 0.58, ranking in the lower quartile and highlighting suboptimal asset utilization relative to peers. Equity ratio of 56.8% falls below the industry median of 63.8%, indicating slightly higher leverage than typical manufacturing companies, though still maintaining conservative capital structure. Revenue growth of 14.6% substantially exceeds the industry median of 2.8% and the upper quartile of 8.1%, demonstrating strong top-line momentum and market share gains relative to sector peers. Current ratio of 251.5% compares favorably to the industry median of 283.0%, indicating adequate but slightly lower liquidity positioning. Financial leverage of 1.76x exceeds the industry median of 1.53x, consistent with the lower equity ratio and suggesting moderately elevated financial risk profile. The company's inventory accumulation and working capital challenges appear more severe than typical industry practice based on the significant YoY inventory increase. (Industry: Manufacturing sector, N=100 companies for core metrics, Comparison: 2025-Q3 period, Source: Proprietary analysis)
Revenue momentum substantially outpacing industry growth demonstrates competitive positioning strength, with 14.6% growth versus 2.8% sector median indicating market share expansion or favorable product mix, though sustainability depends on addressing inventory build-up and confirming demand conversion. Operating margin improvement to 8.3% from 5.9% YoY reflects positive operating leverage, yet the company's profitability metrics including ROE of 4.8% and ROA of 2.7% remain below industry standards, signaling that capital efficiency improvement through accelerated asset turnover and working capital optimization represents the critical path to enhanced shareholder value. Interest coverage of 2.90x combined with 213.7B yen interest-bearing debt creates vulnerability to margin compression under rising rate scenarios, requiring vigilant monitoring of refinancing costs and debt reduction progress, particularly as this metric approaches the threshold warranting caution and limits financial flexibility for growth investments or increased shareholder returns.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.